And

are now a part of the new and improved

search Created with Sketch.
search Created with Sketch.

Advertisement

Dermwire News

News | August 7, 2020

SoftWave Tissue Regeneration Technologies Takes On Cellulite

SoftWave Tissue Regeneration Technologies plans to start a 60-patient study to evaluate the safety and efficacy of the DermaGold device for the temporary improvement in the appearance of cellulite. The company has a...

Read More

News | August 7, 2020

Early Study Demonstrates Roflumilast cream Safe and Effective for Chronic Plaque Psoriasis

Arcutis Biotherapeutics, Inc. shared positive results from a Phase 1/2a trial of its investigational drug topical roflumilast cream for the treatment of chronic plaque psoriasis that were published in the August issue of the Journal of...

Read More

News | August 6, 2020

New Data Supports the Safety and Efficacy of Dupixent in Adults and Children with AD

Two new studies reinforce the efficacy and safety of Dupixent for the treatment of atopic dermatitis in children and adults. In the Phase 3 LIBERTY AD pediatric trial data, nearly three times as many children achieved clear or...

Read More

News | August 5, 2020

New Dermatology Atlas to Highlight and Compare Features of Common Dermatologic Conditions in Different Skin Types

Leaders from academic dermatology and education are joining together to create a comprehensive dermatology atlas to address what they say has become a well-documented gap in dermatology education. The atlas will display side-by-side images...

Read More

News | August 4, 2020

FDA Fast Tracks Leo Pharma’s Delgocitinib Cream for Hand Eczema

Delgocitinib cream, Leo Pharma’s investigational topical pan-Janus kinase (JAK)-inhibitor, has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA) for the potential treatment of adults with...

Read More

Advertisement

The Latest News

Advertisement

View more